Experimental Blood Test Could Speed Autism Diagnosis-U.S. Study
March 16, 2017
(Reuters) – Developers of an experimental blood test for autism say it can detect the condition in more than 96 percent of cases and do so across a broad spectrum of patients, potentially allowing for earlier diagnosis, according to a study released on Thursday. The findings, published in PLoS Computational Biology, are the latest effort to develop a blood test for autism spectrum disorder, which is estimated to affect about 1 in 68 babies. The cause remains a mystery although it has been shown that childhood vaccines are not responsible.